Literature DB >> 1791845

Prohormone-converting enzymes: regulation and evaluation of function using antisense RNA.

B T Bloomquist1, B A Eipper, R E Mains.   

Abstract

Several putative peptide-processing endoproteases have been identified by homology to the yeast Kex2 endoprotease, including furin, PC2, and PC1. However, the question is still open as to which might be involved in peptide posttranslational processing. To enable detailed comparisons of physiological changes in peptide processing with biochemical and molecular biological studies, we cloned rat pituitary cDNAs for PC1 and PC2. The amino acid sequence homologies among rat, human, and mouse PC1, PC2, and furin are consistent with each being a highly conserved but distinct member of a larger family of mammalian subtilisin-like proteases. PC1 and PC2 mRNAs show a restricted distribution among rat tissues and cultured cell lines, consistent with a role in tissue-specific peptide processing; the occurrence of furin mRNA among these tissues and cell lines is much more widespread, being high in many nonneuroendocrine tissues. In the neurointermediate pituitary, PC1 and PC2 mRNAs are strikingly regulated in response to dopaminergic agents, in parallel with mRNAs for POMC, peptidylglycine alpha-amidating monooxygenase, and carboxypeptidase-H. In AtT-20 cells, PC1 mRNA is coregulated with POMC and peptidylglycine alpha-amidating monooxygenase mRNAs in response to CRH and glucocorticoids. When the endogenous PC1 mRNA level in AtT-20 cells is significantly and specifically decreased by stable expression of antisense RNA to PC1, biosynthetic labeling of newly synthesized POMC-derived peptides shows a substantial blockade of normal POMC processing. These data are consistent with a role for PC1 protein in endoproteolysis, either as a processing endoprotease or as the activator of the actual processing endoprotease(s).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1791845     DOI: 10.1210/mend-5-12-2014

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  45 in total

1.  Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway.

Authors:  N L Eskeland; A Zhou; T Q Dinh; H Wu; R J Parmer; R E Mains; D T O'Connor
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Not all secretory granules are created equal: Partitioning of soluble content proteins.

Authors:  Jacqueline A Sobota; Francesco Ferraro; Nils Bäck; Betty A Eipper; Richard E Mains
Journal:  Mol Biol Cell       Date:  2006-09-27       Impact factor: 4.138

3.  Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesis.

Authors:  Xin Zhang; Hui Pan; Bonnie Peng; Donald F Steiner; John E Pintar; Lloyd D Fricker
Journal:  J Neurochem       Date:  2009-12-07       Impact factor: 5.372

Review 4.  Prohormone and proneuropeptide processing. Recent progress and future challenges.

Authors:  M C Beinfeld
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

5.  PACE4: a subtilisin-like endoprotease with unique properties.

Authors:  R E Mains; C A Berard; J B Denault; A Zhou; R C Johnson; R Leduc
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

6.  microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs.

Authors:  Jodi E Eipper-Mains; Drew D Kiraly; Dasaradhi Palakodeti; Richard E Mains; Betty A Eipper; Brenton R Graveley
Journal:  RNA       Date:  2011-06-27       Impact factor: 4.942

Review 7.  Regulation of the biosynthesis of large dense-core vesicles in chromaffin cells and neurons.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

8.  Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids.

Authors:  W Dong; B Seidel; M Marcinkiewicz; M Chrétien; N G Seidah; R Day
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

9.  Synthetic small-molecule prohormone convertase 2 inhibitors.

Authors:  Dorota Kowalska; Jin Liu; Jon R Appel; Akihiko Ozawa; Adel Nefzi; Robert B Mackin; Richard A Houghten; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2008-12-12       Impact factor: 4.436

10.  Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3.

Authors:  S P Smeekens; A G Montag; G Thomas; C Albiges-Rizo; R Carroll; M Benig; L A Phillips; S Martin; S Ohagi; P Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.